Aclaris Therapeutics, Inc. (Nasdaq: ACRS) announced that it has entered into a stock purchase agreement with a group of institutional ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE